Work

Lenalidomide added to bendamustine-rituximab for untreated chronic lymphocytic leukemia (CLL): A phase 1 study.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.7082

Authors: Jeremy S. Abramson, Matthew Steven Davids, Lillian Werner, David Christopher Fisher, Philippe Armand, Philip C. Amrein, Donna S. Neuberg, Ephraim P. Hochberg, Jennifer R. Brown

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604347358

Cites:

Cited by: 4

Related to: 10